Liothyronine (T3) 50 mcg

Liothyronine (T3) 50 mcg contains liothyronine sodium, a synthetic thyroid hormone. In medical practice, it is FDA-approved for hypothyroidism replacement therapy and as a diagnostic agent in thyroid suppression tests. In non-medical bodybuilding settings, it is commonly referenced for its metabolic rate-increasing properties during cutting phases, though such use falls outside approved medical indications.

In medical settings, liothyronine is typically administered once daily, with dosing individualized based on patient response and laboratory findings. In non-medical contexts, liothyronine is commonly referenced at 25–75 mcg per day, sometimes split into multiple doses to smooth out serum level fluctuations.

Liothyronine does not require traditional post-cycle therapy in the same manner as anabolic steroids. However, abrupt discontinuation after prolonged use may be associated with temporary thyroid suppression. A gradual taper is commonly referenced in non-medical contexts to support recovery of natural thyroid function.

Liothyronine sodium is a synthetic form of triiodothyronine (T3), a thyroid hormone that regulates metabolic rate, protein synthesis, and carbohydrate and fat metabolism. It binds to thyroid hormone receptors in cell nuclei, activating gene transcription and influencing nearly every cell in the body. Its rapid onset distinguishes it from levothyroxine (T4), which requires peripheral conversion.

Liothyronine has a rapid onset of action, with peak serum T3 levels occurring approximately 2–4 hours after oral administration. Metabolic effects can appear within hours, though clinical response in hypothyroidism may take days to weeks to fully manifest. This rapid action contrasts with levothyroxine, which may take several weeks to reach full effect.

There is no single thyroid hormone preparation that is universally best. Levothyroxine (T4) is the standard of care for hypothyroidism due to its steady blood levels and long half-life. Liothyronine (T3) has a more rapid onset but produces more significant serum level fluctuations with once-daily dosing. The appropriate choice depends on the clinical context and individual factors.

Liothyronine (T3) and levothyroxine (T4) are both thyroid hormones, but they differ in onset, duration, and need for conversion. T4 requires conversion to T3 in peripheral tissues to become active, while T3 is directly active. Liothyronine has a faster onset but shorter half-life, producing more significant serum level fluctuations than levothyroxine.

Liothyronine and Clenbuterol operate through entirely different mechanisms. Liothyronine is a thyroid hormone that increases metabolic rate through thyroid hormone receptor activation. Clenbuterol is a beta-2 adrenergic agonist that stimulates thermogenesis through a different pathway. Both are referenced in non-medical cutting contexts but are not interchangeable.

In medical contexts, 50 mcg is within the usual maintenance range for hypothyroidism (25–75 mcg daily), though it represents the higher end of that range. The 50 mcg strength provides a single-tablet option for individuals requiring that dose. However, liothyronine has a narrow therapeutic index, and any dose should be evaluated in the context of individual clinical factors.

Liothyronine (T3) 50 mcg is labeled at 50 mcg of liothyronine sodium per tablet. It is supplied as 100 oral tablets per package, giving 5,000 mcg of total labeled content.

Yes. A published laboratory report dated January 18, 2024 measured Liothyronine (T3) 50 mcg at 57.34 mcg per tablet, equivalent to 114.68% of its 50 mcg label claim. The complete report can be viewed in the Lab Reports tab. Laboratory results apply to the tested sample represented by the individual report.